The progression of Alzheimer’s disease was arrested in four patients who received an intravenous antibody treatment over three years, researchers reported at a conference in Vancouver, British Columbia.

Researchers noted that the results were inconclusive since they involved such a small group of patients. But with Alzheimer’s still mostly a mystery to medical science, any small step forward in treatment is good news.

— Posted by Alexander Reed Kelly

MedPage Today:

… The highlight finding, Relkin said, was that 3-year ADAS-Cog and CGIC scores in the four patients who received 0.4 g/kg every 2 weeks throughout the study were the same as at baseline.

Untreated Alzheimer’s disease patients in his clinic nearly always show measurable decline in 3 to 6 months, he said.

Read more

 TRUTHDIG’S JOURNALISM REMAINS CLEAR

The storytellers of chaos tried to manipulate the political and media narrative in 2025, but independent journalism exposed what they tried to hide. When you read Truthdig, you see through the illusion.

Support Independent Journalism.

SUPPORT TRUTHDIG